Global pharma at value: Roche, AZN, MRK, GSK, TAK — deep pipelines, patent cliff fears
| Symbol | Action | Vol | Stop Loss | Take Profit | Size | Links |
|---|---|---|---|---|---|---|
| RHHBY | BUY | 27% | 19.2% below entry | 6.5% above entry | 6.6% | TVYH |
| BAYRY | BUY | 40% | 29.1% below entry | 9.8% above entry | 4.3% | TVYH |
| NVS | BUY | 21% | 15.1% below entry | 5.1% above entry | 8.3% | TVYH |
| TAK | BUY | 20% | 14.7% below entry | 5.0% above entry | 8.6% | TVYH |
| AZN | BUY | 26% | 18.6% below entry | 6.3% above entry | 6.8% | TVYH |
| MRK | BUY | 29% | 20.9% below entry | 7.0% above entry | 6.0% | TVYH |
| LLY | BUY | 38% | 27.4% below entry | 9.2% above entry | 4.6% | TVYH |